Cargando…

Radiotherapy of Breast Cancer—Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer

The international radiotherapy (RT) expert panel has revised and updated the RT guidelines that were accepted in 2020 at the 4th Hungarian Breast Cancer Consensus Conference, based on new scientific evidence. Radiotherapy after breast-conserving surgery (BCS) is indicated in ductal carcinoma in situ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polgár, Csaba, Kahán, Zsuzsanna, Ivanov, Olivera, Chorváth, Martin, Ligačová, Andrea, Csejtei, András, Gábor, Gabriella, Landherr, László, Mangel, László, Mayer, Árpád, Fodor, János
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272418/ https://www.ncbi.nlm.nih.gov/pubmed/35832115 http://dx.doi.org/10.3389/pore.2022.1610378

Ejemplares similares

Breast Cancer Survivorship Programme: Follow-Up, Rehabilitation, Psychosocial Oncology Care. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kahán, Zsuzsanna, et al.
Publicado: (2022)

Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Rubovszky, Gábor, et al.
Publicado: (2022)

Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer
por: Rubovszky, Gábor, et al.
Publicado: (2023)

Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Cserni, Gábor, et al.
Publicado: (2022)

Modern Breast Cancer Surgery 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Mátrai, Zoltán, et al.
Publicado: (2022)

Editorial: Guidelines From the Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kulka, Janina, et al.
Publicado: (2022)

Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Forrai, Gábor, et al.
Publicado: (2022)

Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience
por: Boér, Katalin, et al.
Publicado: (2021)

Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features
por: Turkevi-Nagy, Sándor, et al.
Publicado: (2021)

Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers
por: Szita, Virág Réka, et al.
Publicado: (2022)

Comparison of Cancer Survival Trends in Hungary in the Periods 2001–2005 and 2011–2015 According to a Population-Based Cancer Registry
por: Kenessey, István, et al.
Publicado: (2022)

rs779805 Von Hippel-Lindau Gene Polymorphism Induced/Related Polycythemia Entity, Clinical Features, Cancer Association, and Familiar Characteristics
por: Remenyi, Gyula, et al.
Publicado: (2021)

Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy
por: Olah, Orsolya, et al.
Publicado: (2023)

Comparison of Shear Wave Elastography and Dynamometer Test in Muscle Tissue Characterization for Potential Medical and Sport Application
por: Soldos, Peter, et al.
Publicado: (2021)

Traditional Serrated Adenoma of the Gallbladder, a Case Report
por: Micsik, Tamás, et al.
Publicado: (2022)

Correlation between fibroblast growth factor receptor mutation, programmed death ligand-1 expression and survival in urinary bladder cancer based on real-world data
por: Revesz, Janos, et al.
Publicado: (2023)

Percutaneous tracheostomy: Comparison of three different methods with respect to tracheal cartilage injury in cadavers—Randomized controlled study
por: Bódis, Fruzsina, et al.
Publicado: (2023)

Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement
por: Ceglédi, Andrea, et al.
Publicado: (2023)

Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary
por: Lovas, Szilvia, et al.
Publicado: (2022)

Patient delay and its clinical significance among head and neck cancer patients in Hungary
por: Dános, Kornél, et al.
Publicado: (2023)

Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma
por: Gyulai, Marton, et al.
Publicado: (2023)

Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer
por: Chai, Jie, et al.
Publicado: (2023)

PD-1 and PD-L1 expression in rare lung tumors
por: Gyulai, Marton, et al.
Publicado: (2023)

Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14)
por: Ceglédi, Andrea, et al.
Publicado: (2023)

Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data
por: Hua, Yu, et al.
Publicado: (2021)

NAD+ biosynthesis metabolism predicts prognosis and indicates immune microenvironment for breast cancer
por: Yang, Yuting, et al.
Publicado: (2023)

Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
por: Takács, Ferenc, et al.
Publicado: (2022)

IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study
por: Lőcsei, Zoltán, et al.
Publicado: (2021)

Anterior Gradient 2 is a Significant Prognostic Biomarker in Bone Metastasis of Breast Cancer
por: Li, Jin-Jin, et al.
Publicado: (2022)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

Case Report: Brainstem angiocentric glioma presenting in a toddler child–diagnostic and therapeutic challenges
por: Reisz, Zita, et al.
Publicado: (2023)

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022)

The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC
por: Guti, Eliza, et al.
Publicado: (2022)

Immunohistochemical Expressions of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer
por: Park, Min Hui, et al.
Publicado: (2021)

Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy
por: Pfaendler, Krista S, et al.
Publicado: (2022)

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy
por: Tan, Shirong, et al.
Publicado: (2021)

EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits
por: Bencze, Eszter, et al.
Publicado: (2022)

Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer
por: Paszt, Attila, et al.
Publicado: (2022)

Grade Group accuracy is improved by extensive prostate biopsy sampling, but unrelated to prostatectomy specimen sampling or use of immunohistochemistry
por: Korpás, Kristóf Levente, et al.
Publicado: (2023)

Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination
por: Deme, Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_faktsivpdja4nf7rrtnba58ih0